Kenvue Inc.
KVUE
Rang in aandelen
#662
Kenvue Inc. functions as a global leader in the consumer health sector. The... Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Aandeelprijs
$19.29
Marktkapitalisatie
$37.05B
Verandering (1 dag)
2.23%
Verandering (1 jaar)
28.94%
Land
US
Handel Kenvue Inc. (KVUE)
Categorie
Consumer Defensive
Dividendrendementgeschiedenis voor Kenvue Inc. (KVUE)
Het dividendrendement (TTM) van Kenvue Inc. (aandelsymbool: KVUE) per 2023-12-31 is: 36.56%
Gemiddeld dividendrendement over de afgelopen 5 jaar: 8.08%
Gemiddeld dividendrendement over de afgelopen 5 jaar: 8.08%
Dividendrendementgeschiedenis van Kenvue Inc. (KVUE) van 2019 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
| Jaar | Dividendrendement | Wijzigen |
|---|---|---|
| 2026 (TTM) | 5.79% | 51.17% |
| 2024 | 3.83% | -89.52% |
| 2023 | 36.56% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
| Bedrijf | Dividendrendement | Land |
|---|---|---|
| 2.76% |
US
|
|
| 1.88% |
FR
|
|
| 2.26% |
US
|
|
| 2.16% |
IN
|
|
| 1.38% |
US
|
